All patients* | Patients with cerebral infarct, n (%)* | Patients with cerebral hemorrhage, n (%)* | Patients with cranial trauma, n (%)* | Patients with intracranial malignancy, n (%)* | |
Total number | 371 | 73 (20) | 105 (28) | 116 (31) | 77 (21) |
Male | 224 (60) | 40 (55) | 59 (56) | 78 (67) | 47 (61) |
Female | 147 (40) | 33 (45) | 46 (44) | 38 (33) | 30 (39) |
Median age (years) | 69.6 | 73.3 | 75.26 | 63.3 | 66.7 |
Median follow-up (years) | 0.4 | 0.92 | 0.44 | 1.95 | 1.16 |
Imaging-confirmed venous thromboembolism | |||||
PE | 159 (43) | 36 (49) | 52 (49.5) | 27 (23) | 44 (57) |
DVT | 154 (42) | 41 (56) | 49 (47) | 24 (21) | 40 (52) |
PE + DVT | 68 (18) | 20 (27) | 20 (19) | 9 (8) | 19 (25) |
Indication for IVC filter | |||||
Contraindication to anticoagulation | 251 (68) | 55 (75) | 83 (79) | 49 (42) | 64 (83) |
Prophylactic | 83 (22) | 2 (3) | 15 (14) | 61 (52.5) | 5 (7) |
Added protection | 22 (6) | 8 (11) | 4 (4) | 4 (3.5) | 6 (8) |
Failure of anticoagulation | 6 (2) | 3 (4) | 1 (1) | 1 (1) | 1 (1) |
Complication of anticoagulation | 9 (2) | 5 (7) | 2 (2) | 1 (1) | 1 (1) |
Type of filters used | |||||
TrapEase | 252 (68) | 47 (64) | 80 (76) | 66 (57) | 59 (77) |
OptEase | 41 (11) | 12 (16) | 15 (14) | 9 (8) | 5 (7) |
Recovery | 38 (10) | 6 (8) | 3 (3) | 25 (22) | 4 (5) |
Gunther Tulip | 18 (5) | 3 (4) | 3 (3) | 7 (6) | 5 (7) |
Vena Tech | 8 (2) | 2 (3) | 0 | 5 (4) | 1 (1) |
Simon-Nitinol | 6 (2) | 2 (3) | 2 (2) | 2 (1.5) | 0 |
Celect | 5 (1) | 0 | 1 (1) | 2 (1.5) | 2 (2) |
Greenfield | 1 (0.3) | 0 | 1 (1) | 0 | 0 |
Bird’s Nest | 1 (0.3) | 1 (2) | 0 | 0 | 0 |
Unspecified | 1 (0.3) | 0 | 0 | 0 | 1 (1) |
↵* Denominator is the number of patients in that particular group.
PE, pulmonary embolism; DVT, deep venous thrombosis; IVC, inferior vena cava.